Literature DB >> 8808407

Dominant negative expression of a cytoplasmically deleted mutant of XB/U-cadherin disturbs mesoderm migration during gastrulation in Xenopus laevis.

M Kühl1, S Finnemann, O Binder, D Wedlich.   

Abstract

XB/U-cadherin is a maternal Xenopus cadherin which mediates interblastomere adhesion in early embryogenesis. In order to explore its role in gastrulation, we expressed a cytoplasmic deletion mutant of XB/U-cadherin (XB delta c38) under the control of the CMV promoter in Xenopus embryos. This truncated XB-cadherin fails to form complexes with catenins and does not mediate cell-cell aggregation as shown by transfection of mouse Ltk- cells. Injections of the deletion for XB/U-cadherin into the dorsal-marginal region of four cell stage embryos resulted in a dominant negative expression of the cadherin mutant after MBT. Two different phenotypes were observed in a dose dependent manner: high doses (125-250 pg DNA) led to severe distortions of the gastrulation movement. Involution of the mesoderm was impaired, posterior mesoderm migrated laterally around the blastopore and formed two bands of axial tissue. Low doses (up to 50 pg DNA) resulted in embryos of a posteriorized phenotype with disorganized neural structures. Both phenotypes could be rescued by coinjection of cDNA constructs containing wild-type XB/U-cadherin. Injections of constructs encoding a XB/U-cadherin protein truncated both in its extracellular and cytoplasmic domains yielded normal phenotypes. These results suggest that a proper function of XB/U-cadherin is essential for mesoderm movements during gastrulation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8808407     DOI: 10.1016/0925-4773(95)00462-9

Source DB:  PubMed          Journal:  Mech Dev        ISSN: 0925-4773            Impact factor:   1.882


  8 in total

1.  Activated mutants of SHP-2 preferentially induce elongation of Xenopus animal caps.

Authors:  A M O'Reilly; S Pluskey; S E Shoelson; B G Neel
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

2.  Regulation of Xenopus gastrulation by ErbB signaling.

Authors:  Shuyi Nie; Chenbei Chang
Journal:  Dev Biol       Date:  2006-11-10       Impact factor: 3.582

3.  Beta-arrestin is a necessary component of Wnt/beta-catenin signaling in vitro and in vivo.

Authors:  Vítezslav Bryja; Dietmar Gradl; Alexandra Schambony; Ernest Arenas; Gunnar Schulte
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-10       Impact factor: 11.205

4.  Reduced U snRNP assembly causes motor axon degeneration in an animal model for spinal muscular atrophy.

Authors:  Christoph Winkler; Christian Eggert; Dietmar Gradl; Gunter Meister; Marieke Giegerich; Doris Wedlich; Bernhard Laggerbauer; Utz Fischer
Journal:  Genes Dev       Date:  2005-10-01       Impact factor: 11.361

5.  (18)F-MCL-524, an (18)F-Labeled Dopamine D2 and D3 Receptor Agonist Sensitive to Dopamine: A Preliminary PET Study.

Authors:  Sjoerd J Finnema; Vladimir Stepanov; Ryuji Nakao; Anna W Sromek; Tangzhi Zhang; John L Neumeyer; Susan R George; Philip Seeman; Michael G Stabin; Cathrine Jonsson; Lars Farde; Christer Halldin
Journal:  J Nucl Med       Date:  2014-05-01       Impact factor: 10.057

6.  Paraxial protocadherin coordinates cell polarity during convergent extension via Rho A and JNK.

Authors:  Frank Unterseher; Joerg A Hefele; Klaudia Giehl; Eddy M De Robertis; Doris Wedlich; Alexandra Schambony
Journal:  EMBO J       Date:  2004-08-05       Impact factor: 11.598

7.  LI-cadherin-mediated cell-cell adhesion does not require cytoplasmic interactions.

Authors:  B Kreft; D Berndorff; A Böttinger; S Finnemann; D Wedlich; M Hortsch; R Tauber; R Gessner
Journal:  J Cell Biol       Date:  1997-03-10       Impact factor: 10.539

8.  beta-Catenin controls cell sorting at the notochord-somite boundary independently of cadherin-mediated adhesion.

Authors:  Wolfgang E Reintsch; Anette Habring-Mueller; Renee W Wang; Anne Schohl; François Fagotto
Journal:  J Cell Biol       Date:  2005-08-15       Impact factor: 10.539

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.